| abstract |
Use of a renin-angiotensin system inhibitor for the preparation of a medicament for the treatment or prevention of stroke or its recurrence in a human patient, in which the stroke is thrombotic or hemorrhagic, cerebrovascular or of accidental origin and in which said inhibitor is selected from quinapril, captopril, perindopril, trandolapril, enalapril, moexiprile, fosinoprile, ramiprile, cilazapril, imidapril, spirapril, temocapril, benazepril, alaceprile, delapril, moveltiprile, canartanartan, canartanartan, canartanartan, canartanartan, canartanartan, canartanartan, canartanartan, canartanartan, canartanartostan Telmisartan |